5Kay E,O'Dowd J,Thomas R, et al. Mild abnormalities in liver histology associated with chronic hepatitis:distinction from normal liver histology. J Clin Pathol, 1997,50: 929.
5UDOMUKSORN W, ELLIOT D J, LEWIS B C, et al. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP- glucuronosyltransferase 1A substrates [ J ]. Pharmacogenet Genomics, 2007, 17 (12): 1017-1029.
6HSIEH T Y, SHIU T Y, HUANG S M. Molecular pathogenesis of Gilbert's syndrome : decreased TATA-binding protein binding affinity of UGT1A1 gene promoter [ J]. Pharmacogenet Genomics, 2007, 17 (4): 229-236.
7Vitek L,Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease:a protective effect of elevated bilirubin levels [J]. Atherosclerosis, 2002,160:449-456.
8Clarke DJ, Moghrabi N, Monaghan G,et al. Genetic defects of the UDP-glucuronosyltransferase-1 ( UGT1 ) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias[J]. Clin Chim Acta, 1997,266:63-74.
9Kohle C, Mohrle B, Munzel PA,et al. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome(UGT1A1"28)with other polymorphisms of the UDP-glucuronosyltransferase-1 locus( UGT1A6'2 and UGT1A7'3) in Caucasians and Egyptians [ J ]. Biochem Pharmacol, 2003,65:1521-1527.
10Sugatani J, Yamakawa K, Yoshinari K, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia [ J ]. Biochem Biophys Res Commun,2002.292:492 -497.
